Fever on Tirzepatide: What's Normal, What Isn't, and When to Act

Step 1, Check whether your fever is systemic or just local

The first practical step takes under a minute. Use a thermometer to confirm your temperature. A localised warm patch, redness, or mild swelling at the injection site is a separate thing entirely from a whole-body raised temperature, and the two call for different responses.

Injection-site reactions (including warmth, itching, and redness around where you injected) are listed as common in the NHS patient information for tirzepatide. They typically appear within hours of the injection and settle without treatment. Rotating your injection site each week (abdomen, thigh, upper arm) helps reduce their frequency. If the redness is spreading beyond the injection site, developing into a firm raised lump, or not resolving after a few days, that does need a clinician's eye.

A true systemic fever (temperature above 38°C) is a different signal. It means your immune system is responding to something, and tirzepatide is unlikely to be the direct cause. Ask yourself: is there a concurrent illness, a cold, a urine infection, or anything else you might have picked up? Often there is a straightforward explanation. The concern with tirzepatide specifically is that some of the medicines' rarer side effects can also produce fever as part of a wider picture, so you want to know which picture you're in.

Step 2, Know which combinations of symptoms matter most

Fever alongside stomach pain deserves particular attention on tirzepatide. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines drew attention to acute pancreatitis: a serious but uncommon complication that can present as severe, persistent pain in the upper abdomen, sometimes radiating into the back, with or without vomiting, and occasionally with fever. If that combination describes what you're feeling, do not wait. Call 111 or go to A&E.

Gallbladder problems are another listed side effect of tirzepatide. Gallstones or gallbladder inflammation (cholecystitis) can cause upper-right abdominal pain, nausea, and fever, and they are somewhat more common in people losing weight rapidly on any treatment. If you have fever with pain in the right side of your abdomen, particularly after eating, that warrants same-day medical assessment.

There is also a dehydration risk worth understanding. Tirzepatide commonly causes nausea and vomiting, particularly in the first weeks at a new dose. If a concurrent illness is also causing you to vomit or gives you diarrhoea, dehydration can develop quickly, and that in turn affects how the kidneys function. Fever combined with very little urine output, extreme thirst, or dizziness on standing is a reason to contact 111 or a prescriber promptly. If you have questions about how to handle illness while on treatment, the team at nume's aftercare support is available seven days a week.

Step 3, Understand what to do about your tirzepatide dose during illness

A common question is whether to skip or delay an injection when you're unwell. That decision belongs with your prescriber or the clinical team managing your treatment, not with a general guide online, and not with the Patient Information Leaflet alone, which is not written to address every scenario. What the SmPC does confirm is that missed doses, timing changes, and any decision to pause treatment should be made with clinical input, particularly if there is an underlying cause for the illness being investigated.

People often search for fever specifically in the context of Mounjaro, which is the brand name for tirzepatide in the UK. The clinical picture is the same either way: tirzepatide is tirzepatide, and the same cautions apply regardless of how you found it. If you're still deciding which treatment might be right for you, the tirzepatide overview covers the full clinical profile, and if you're interested in how tirzepatide compares to other options, our guide to Mounjaro versus tirzepatide sets out the brand relationship clearly.

One thing worth noting: some readers arrive here after developing what they think are hay-fever-type symptoms (sneezing, runny nose, watery eyes) and wondering whether their injection caused them. This is a separate question, and we've looked at it in our piece on tirzepatide and hay fever. It's an easy thing to mix up at the start of treatment.

Step 4, Report and follow up

Any side effect you suspect may be linked to tirzepatide can be reported directly to the MHRA via the Yellow Card scheme. You don't need to be certain it's the medicine, a suspected link is enough. These reports are how regulators identify patterns in the real world that clinical trials may not have been large enough to detect, and they genuinely inform future prescribing guidance.

Follow up with your prescribing team after any significant illness during treatment. If you're managing your tirzepatide treatment privately and don't have a straightforward route back to whoever prescribed it, that's something to resolve before you need it. The frequently asked questions on this site include guidance on aftercare and what to do between doses. And if you're approaching tirzepatide for the first time and weighing up the full picture, including what treatment costs and what a private prescription includes, our guide to Mounjaro cost in the UK sets out what to expect.

Tirzepatide is a clinically supervised treatment, and if you want a broader look at how the medicine works and who it suits, our tirzepatide l guide covers the detail in full. If your temperature rises and something feels wrong, the right response is to get a clinician involved, not to wait for the weekly injection window to pass.